Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Charles Simone, MD, FASTRO

New York Proton Center and Memorial Sloan Kettering Cancer Center
New York, NY, United States

Charles B. Simone, II, MD, FACRO is Research Professor and Chief Medical Officer of New York Proton Center and Full Member in Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is internationally recognized for developing innovative thoracic oncology trials and proton therapy for thoracic malignancies and reirradiation. Dr. Simone was previously Chief of Thoracic Oncology at University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in Radiation Oncology at Penn. He was then Medical Director of Maryland Proton Treatment Center, Chair of the Clinical Research Committee for Marylands Comprehensive Cancer Center, proton Fellowship Director, and Director of the Stereotactic Radiation Therapy Program. He completed his undergraduate and medical training at UPenn and radiation oncology residency at NCI/NIH, where he was chief resident. Dr. Simone is an NIH, NSF, and DOD-funded investigator, published >500 scientific articles/chapters, and given >475 lectures to national/international audiences. He is the national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (NRG Oncology=5, SWOG=1, ECOG-ACRIN=1, PCG=1) and three-time ARRO Educator of the Year winner. He is the Proton Collaborative Group Board President. He Chairs the PCG Lung Committee, ASTRO Lung Resource Panel Committee, ASTRO Blue Ribbon Lung Panel, NRG Oncology Particle Therapy Work Group, American Radium Society AUC Thoracic Committee, American College of Radiation Oncology Abstracts Committee, NCI/Radiosurgery Society GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group, Varian FlashForward Consortium Clinical Committee, Varian ProtonConnect User Group, and multiple PTCOG subcommittees. He is Editor-in-Chief of Annals of Palliative Medicine.

Disclosures:

  • Employment: New York Proton Center, Memorial Sloan Kettering:Research Professor and Chief Medical Officer:Employee
  • Compensation: Novocure: Honoraria-End Date: 4/21/2022 ;Varian Medical System: Honoraria-End Date: 8/03/2022
  • Ownership: none
  • Leadership: American Radium Society:Chair, Thoracic Appropriate Use Criteria Committee;American Society for Radiation Oncology:Chair, Lung Resource Panel; Vice Chair, Lung Track;Annals of Palliative Medicine:Editor-in-Chief;NRG Oncology:Chair, Particle Therapy Work Group;Proton Collaborative Group:President of the Board ; Chair, Lung Committee

Presentation(s):